@inproceedings{inproceedings, title  = {{A salvage autologous stem cell transplant (ASCT2) induces superior overall survival following bortezomib-containing re-induction therapy for relapsed multiple myeloma (MM): Results from the Myeloma X (Intensive) Trial}},

 url = {{}},

 year = {{2016}},

 month = {{4}},

 author = {{Cook G and Williams C and Cairns DA and Hockaday A and Cavenagh JD and Snowden JA and Parrish C and Yong K and Cavet J and Hunter H and Bird JM et al}},

 volume = {{173}},

 journal = {{BRITISH JOURNAL OF HAEMATOLOGY}},

 pages = {{5-6}},

 note = {{Accessed on 2024/12/22}}}